What's New
- 2025.01.07 New!
- Additional Indication of Sclerotherapy of Venous Malformations for OLDAMIN for Injection 1g in Japan
- 2024.12.06 New!
- Regarding fake online social network advertisements
- 2024.01.05
- In regards to Ishikawa Noto Earthquake (final report)
- 2024.01.02
- In regards to Ishikawa-Noto Earthquake(second report)
- 2024.01.01
- In regards to Ishikawa-Noto Earthquake (preliminary report)
- 2021.02.22
- Relocation of Tokyo Branch Office
- 2020.09.24
- Fuji Excipient Webinar September 24
- 2020.06.23
- Fuji Excipient Webinar June 23-24
- 2020.06.17
- Fuji increases its production capacity for the API manufacturing of Avigan® Tablet.
- 2019.09.25
- Hiroshi Nishida assumes his new role as a CEO & President starting October 1, 2019
- 2019.04.01
- Business Transfer of ULCERLMIN® for the Treatment of Gastritis/Peptic Ulcer from Chugai Pharmaceutical to Fuji Chemical Industries
- 2017.06.26
- Oldamin Injection 1g is approved for an additional indication (sclerosing regression of gastric varices) in Japan
Event
- 2020.06.15
- June 23-24 Fuji Excipient Webinar (Asia Pacific and Europe)
- 2019.10.11
- AAPS 2019 – Nov. 5–7
- 2019.10.10
- CPhI Worldwide 2019 - Nov. 5-7
- 2019.08.04
- Contract Pharma 2019 - Sept. 26-27
- 2019.05.27
- Interphex Japan 2019 - July 3-5
- 2019.03.27
- CPhI North America 2019 - April 30 - May 2
- 2018.06.11
- AAPS 2018 – Nov. 4–7
Technical Newsletter
- 2018.12.12
- Fuji Spray Drying Newsletter Vol.9
- 2018.08.08
- Fuji Spray Drying Newsletter Vol.8
- 2018.06.20
- Fuji Spray Drying Newsletter Vol.7
- 2018.04.04
- Fuji Spray Drying Newsletter Vol.6
- 2018.03.21
- Fuji Spray Drying Newsletter Vol.5
- 2018.03.07
- Fuji Spray Drying Newsletter Vol.4
- 2018.02.28
- Fuji Spray Drying Newsletter Vol.3
Affiliate Company
- Marketing and sales of bulk pharmaceutical products in the U.S.A
- Japan
- Sweden
- USA
- Singapore
- India
- Our philanthropic activity acquired a collection of worldwide fine arts and antiquities.